|
11 Companies |
|
26 Products |
|
26 Products |
|
43 Mechanisms of Action |
|
1 Trial |
|
153 News |
|
| «1234 |
- Zolinza (vorinostat) / Merck (MSD)
Enrollment closed: Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast (clinicaltrials.gov) - Sep 24, 2012
P1, N=17, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting
- Trial completion: Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer (clinicaltrials.gov) - Jun 12, 2012
P1, N=34, Completed, Sponsor: University of Medicine and Dentistry New Jersey
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- letrozole / Generic mfg.
Enrollment open: DCIS: Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ (clinicaltrials.gov) - Jun 5, 2012
P2, N=115, Recruiting, Sponsor: Cancer and Leukemia Group B
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- tamoxifen / Generic mfg.
Trial withdrawal: Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy (clinicaltrials.gov) - Apr 23, 2012
P2, N=0, Withdrawn, Sponsor: Northwestern University
Not yet recruiting --> Recruiting Terminated --> Withdrawn
- tamoxifen / Generic mfg.
Enrollment change: Ductal Lavage in Assessing Women With Early Breast Cancer or at High Risk of Developing Breast Cancer and Who Are Eligible For Tamoxifen Therapy (clinicaltrials.gov) - Apr 23, 2012
P2, N=0, Withdrawn, Sponsor: Northwestern University
Terminated --> Withdrawn N=262 --> 0
- letrozole / Generic mfg.
Trial initiation date: DCIS: Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ (clinicaltrials.gov) - Feb 15, 2012
P2, N=115, Recruiting, Sponsor: Cancer and Leukemia Group B
N=262 --> 0 Initiation date: Oct 2011 --> Feb 2012
- Enrollment change: Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers (clinicaltrials.gov) - Jan 29, 2012
P=N/A, N=49, Completed, Sponsor: City of Hope Medical Center
Initiation date: Oct 2011 --> Feb 2012 N=104 --> 49
- Trial completion: Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers (clinicaltrials.gov) - Jan 29, 2012
P=N/A, N=49, Completed, Sponsor: City of Hope Medical Center
N=104 --> 49 Recruiting --> Completed
- Trial completion: Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer (clinicaltrials.gov) - Jan 29, 2012
P=N/A, N=52, Completed, Sponsor: City of Hope Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- || New P3 trial, Surgery: Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer (clinicaltrials.gov) - Dec 14, 2011
P3, N=565, Completed, Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Trial withdrawal, Surgery: Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer (clinicaltrials.gov) - Dec 6, 2011
P2, N=0, Withdrawn, Sponsor: Case Comprehensive Cancer Center
Active, not recruiting --> Completed Terminated --> Withdrawn
- ||| Enrollment change: Three Different Programs of Paced Breathing in Treating Hot Flashes in Women (clinicaltrials.gov) - Dec 4, 2011
P2, N=105, Completed, Sponsor: Mayo Clinic
Terminated --> Withdrawn N=150 --> 105
- |||| Trial completion: Three Different Programs of Paced Breathing in Treating Hot Flashes in Women (clinicaltrials.gov) - Dec 4, 2011
P2, N=105, Completed, Sponsor: Mayo Clinic
N=150 --> 105 Active, not recruiting --> Completed
- | letrozole / Generic mfg.
New P2 trial: DCIS: Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ (clinicaltrials.gov) - Sep 21, 2011
P2, N=115, Recruiting, Sponsor: Cancer and Leukemia Group B
- || carboplatin / Generic mfg.
New P2/3 trial: GeparSixto: Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer (clinicaltrials.gov) - Aug 30, 2011
P2/3, N=595, Completed, Sponsor: German Breast Group